semaglutide medicaid coverage Louisiana might add for popular obesity treatment drugs • Louisiana Illuminator Pa.'s Medicaid rollback on obesity

Semaglutide Supply Chain & Access Challenges Miranda Schmalfuhs Scott Brunner, CEO, and Tenille Davis, Chief Advocacy Officer, of the Alliance for Pharmacy Compounding discuss specific challenges that have arisen in the supply chain for semaglutide and how to ensure that patients continue to have access to essential medications, particularly during shortages

Outcomes of GLP-1RA-related hypoglycemia We assessed the proportions of hospitalization and fatality resulting from hypoglycemia adverse events after various GLP-1RA administrations to determine the prognosis of GLP-1RA-related hypoglycemia

Acta Neuropsychiatrica

Head-to-head trials show tirzepatide producing 3-5 percentage points greater weight loss at comparable timepoints